These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12076998)

  • 21. A linkage study in two families with multiple sclerosis and healthy members with oligoclonal CSF immunopathy.
    Haghighi S; Andersen O; Nilsson S; Rydberg L; Wahlström J
    Mult Scler; 2006 Dec; 12(6):723-30. PubMed ID: 17262999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of the HLA-DRB1*15 allele group and the DRB1*1501 and DRB1*1503 alleles with multiple sclerosis in White and Mulatto samples from Brazil.
    Brum DG; Barreira AA; Louzada-Junior P; Mendes-Junior CT; Donadi EA
    J Neuroimmunol; 2007 Sep; 189(1-2):118-24. PubMed ID: 17681614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures.
    Okuda DT; Srinivasan R; Oksenberg JR; Goodin DS; Baranzini SE; Beheshtian A; Waubant E; Zamvil SS; Leppert D; Qualley P; Lincoln R; Gomez R; Caillier S; George M; Wang J; Nelson SJ; Cree BA; Hauser SL; Pelletier D
    Brain; 2009 Jan; 132(Pt 1):250-9. PubMed ID: 19022862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-DRB1*15 association with multiple sclerosis is confirmed in a multigenerational Italian family.
    Mosca L; Mantero V; Penco S; La Mantia L; De Benedetti S; Marazzi MR; Spreafico C; Erminio C; Grassi L; Lando G; Zagaria M; Agostoni E; Protti A
    Funct Neurol; 2017; 32(2):83-88. PubMed ID: 28676141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-DRB1 and disease outcome in multiple sclerosis.
    Weatherby SJ; Thomson W; Pepper L; Donn R; Worthington J; Mann CL; Davies MB; Fryer AA; Boggild MD; Young CA; Jones PW; Strange RC; Ollier WE; Hawkins CP
    J Neurol; 2001 Apr; 248(4):304-10. PubMed ID: 11374095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between HLA-DRB1 alleles and optic neuritis in Irish patients and the risk of developing multiple sclerosis.
    Tuwir I; Dunne C; Crowley J; Saddik T; Murphy R; Cassidy L
    Br J Ophthalmol; 2007 Oct; 91(10):1288-92. PubMed ID: 17895416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia.
    Marrosu MG; Murru R; Murru MR; Costa G; Zavattari P; Whalen M; Cocco E; Mancosu C; Schirru L; Solla E; Fadda E; Melis C; Porru I; Rolesu M; Cucca F
    Hum Mol Genet; 2001 Dec; 10(25):2907-16. PubMed ID: 11741834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA class II alleles and multiple sclerosis in Tunisian patients.
    Messadi A; Najiba FM; Ouerhani S; Zaweli J; Louatti I; Layouni S; Nciri B; Bouaicha G; Kouki W; Yedeas M; Raies A; Mrissa R; Gritli N
    Clin Neurol Neurosurg; 2010 Dec; 112(10):849-52. PubMed ID: 20691532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for linkage disequilibrium between HLA-DRB1 gene and multiple sclerosis. The French Research Group on Genetic Susceptibility to MS.
    Yaouanq J; Semana G; Eichenbaum S; Quelvennec E; Roth MP; Clanet M; Edan G; Clerget-Darpoux F
    Science; 1997 May; 276(5313):664-5. PubMed ID: 9157540
    [No Abstract]   [Full Text] [Related]  

  • 30. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.
    Brynedal B; Duvefelt K; Jonasdottir G; Roos IM; Akesson E; Palmgren J; Hillert J
    PLoS One; 2007 Jul; 2(7):e664. PubMed ID: 17653284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for novel DRB1*15 allele association among clinically definite multiple sclerosis patients from Mumbai, India.
    Kankonkar S; Jeyanti G; Singhal BS; Shankarkumar U
    Hum Immunol; 2003 Apr; 64(4):478-82. PubMed ID: 12651075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A method for simple and accurate identification of the multiple sclerosis associated allele HLA-DRB1*1501 in neuroscience research laboratories.
    Cisneros E; Moraru M; de Pablo R; Vilches C
    J Neuroimmunol; 2010 Aug; 225(1-2):143-8. PubMed ID: 20493561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A genome-wide screen for linkage disequilibrium in Australian HLA-DRB1*1501 positive multiple sclerosis patients.
    Ban M; Sawcer SJ; Heard RN; Bennetts BH; Adams S; Booth D; Perich V; Setakis E; Compston A; Stewart GJ
    J Neuroimmunol; 2003 Oct; 143(1-2):60-4. PubMed ID: 14575915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families.
    Gourraud PA; McElroy JP; Caillier SJ; Johnson BA; Santaniello A; Hauser SL; Oksenberg JR
    Ann Neurol; 2011 Jan; 69(1):65-74. PubMed ID: 21280076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
    Stankovich J; Butzkueven H; Marriott M; Chapman C; Tubridy N; Tait BD; Varney MD; Taylor BV; Foote SJ; ; Kilpatrick TJ; Rubio JP
    Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis.
    Ramagopalan SV; Byrnes JK; Dyment DA; Guimond C; Handunnetthi L; Disanto G; Yee IM; Ebers GC; Sadovnick AD
    J Hum Genet; 2009 Sep; 54(9):547-9. PubMed ID: 19629136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linkage analysis of HLA class II genes in Swedish multiplex families with multiple sclerosis.
    Fogdell A; Olerup O; Fredrikson S; Vrethem M; Hillert J
    Neurology; 1997 Mar; 48(3):758-62. PubMed ID: 9065561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis.
    Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T
    J Neurol Sci; 2010 Nov; 298(1-2):96-100. PubMed ID: 20810130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multiple sclerosis with early onset: pathogenesis, clinical characteristics, possibilities in the treatment of its pathogenesis].
    Maslova OI; Bykova OV; Guseva MR; Sidorenko EI; Boĭko SIu; Sudomoina MV; Studenikin VM; Shchelkovskiĭ VI; Favorova OO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; Suppl():46-51. PubMed ID: 12418392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The HLA locus and multiple sclerosis in Sicily.
    Brassat D; Salemi G; Barcellos LF; McNeill G; Proia P; Hauser SL; Oksenberg JR; Savettieri G
    Neurology; 2005 Jan; 64(2):361-3. PubMed ID: 15668443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.